𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The X-gene of human hepatitis B virus transactivates the c-jun and α-fetoprotein genes

✍ Scribed by M. X. Zhou; M. Watabe; K. Watabe

Publisher
Springer Vienna
Year
1994
Tongue
English
Weight
855 KB
Volume
134
Category
Article
ISSN
1432-8798

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The hepatitis B virus X protein up-regul
The hepatitis B virus X protein up-regulates tumor necrosis factor α gene expression in hepatocytes
✍ Enrique Lara-Pezzi; Pedro L. Majano; Marta Gómez-Gonzalo; Carmelo García-Monzón; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

Human hepatocytes infected by hepatitis B virus (HBV) produce the proinflammatory cytokine, tumor necrosis factor (TNF-). In this study, we explored the mechanism of induction of TNF- synthesis by HBV. We found that the stable HBV-transfected hepatoma cell line, 2. 2.15, expressed high-molecular-wei

Gene therapy for α-fetoprotein-producing
Gene therapy for α-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
✍ F Kanai; Y Shiratori; Y Yoshida; H Wakimoto; H Hamada; Y Kanegae; I Saito; H Nak 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

lacZ gene driven by the b-actin -based promoter. Ex-SEE EDITORIAL ON PAGE 1696. pression of the HSVtk gene by adenovirus from AFP promoter/enhancer (AdAFPtk) induced the cells sensitive to ganciclovir (GCV) in the AFP-producing cell We have developed a recombinant replication-deline efficiently, but

Expression of α-fetoprotein and albumin
Expression of α-fetoprotein and albumin genes in human hepatocellular carcinomas: Limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy
✍ Souhei Ohguchi; Harushige Nakatsukasa; Toshihiro Higashi; Kozo Ashida; Kazuhiro 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 1 views

For an approach of gene therapy for hepatocellular carcinoma (HCC), transcriptional regulatory sequence (TRS) of either alpha-fetoprotein (AFP) or albumin has been used for targeting cancer cells. To examine the feasibility of using TRSs of these genes for possible gene therapy of HCCs, the cellular